Integrated Renal Sciences Private Limited
About Integrated Renal Sciences Private Limited
Data last updated:
Integrated Renal Sciences Private Limited is a private limited company based in New Delhi, Delhi, India, a subsidiary of Dicopa Healthcare Private Limited. It operates in the renal care and dialysis clinics segment of the healthcare sector. It was incorporated on 16 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC331039.
The company has an authorised share capital of ₹1.31 Cr and a paid-up capital of ₹1.24 Cr. It is led by directors including Vikas Verma and Ashish Tyagi.
Its last annual general meeting (AGM) was held on 26 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No.25A & 25B Hauz Rani Malviya Nagar, New Delhi, Delhi, India – 110017.
As per the financials filed for FY 2025, the company reported a revenue of ₹23.66 Cr, a growth of 54% compared to the previous year. For the same year it recorded a net loss of ₹3.14 Cr (net margin -13.3%) and EBITDA of -₹2.37 Cr (EBITDA margin -10%). Revenue has grown at a compounded annual rate (CAGR) of 374% over three years.
Its group structure includes 2 subsidiaries.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressNo.25A & 25B Hauz Rani Malviya Nagar, New Delhi, Delhi, India – 110017
- IndustryHealthcare, Renal Care & Dialysis Clinics
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Integrated Renal Sciences Private Limited
The main business activity of Integrated Renal Sciences is human health and social work activities. In detail, this covers human health activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Integrated Renal Sciences Private Limited FY 2024 filings available
Integrated Renal Sciences Private Limited reported revenue of ₹23.66 Cr (up 54% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Integrated Renal Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 374% over three years, including 54% growth in the latest year. EBITDA rose 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Integrated Renal Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹2.37 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹3.14 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Integrated Renal Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -10% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -13.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Integrated Renal Sciences are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Integrated Renal Sciences Private Limited
Integrated Renal Sciences has 4 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikas Verma | Director | 25 May 2021 | 5 Years 4 Months | Current |
| Ashish Tyagi Also directs: 7 Med India Private Limited, Timestream Technologies Private Limited, Dicopa Healthcare Private Limited and 2 more | Director | 12 Jun 2018 | 8 Years 4 Months | Current |
| Rakesh Kumar Thakur | Director | 16 Mar 2018 | 8 Years 7 Months | Current |
| Mayank Sharma | Director | 25 May 2021 | 5 Years 4 Months | Current |
Peer Comparison of Integrated Renal Sciences Private Limited
Integrated Renal Sciences Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Renal Care). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rahi Care Private Limited | ₹39.99 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Chandigarh, India |
| Fresenius Medical Care Dialysis Services India Private Limited | ₹37.49 Cr (FY 2023) | •••• | •••• | 1.0% | •••• | Delhi, India |
| Asian Institute of Nephrology and Urology (Siliguri) Private Limited | ₹27.07 Cr (FY 2025) | •••• | •••• | 29.0% | •••• | Mumbai, Maharashtra, India |
| Dr Raghoji Kidney Hospital and Research Centre Private Limited | ₹25.96 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Solapur, Maharashtra, India |
| DM Hospitals Private Limited | ₹24.54 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Kolkata, West Bengal, India |
| Integrated Renal Sciences Private Limited this company | ₹23.66 Cr (FY 2025) | •••• | •••• | 54.0% | •••• | New Delhi, Delhi, India |
| Asian Institute of Nephrology and Urology (Chennai) Private Limited | ₹19.55 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Hyderabad, Telangana, India |
| Asian Institute of Nephrology and Urology (Vizag) Private Limited | ₹19.5 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Hyderabad, Telangana, India |
| Fusion Kidney Care Private Limited | ₹18.4 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Ahmedabad, Gujarat, India |
| Tejnaksh Healthcare Limited Listed | ₹13.3 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Jogeshwari East, Maharashtra, India |
| Regency Nephrocare Private Limited | ₹11.34 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Kanpur, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Integrated Renal Sciences by revenue in the Healthcare industry (Renal Care), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Integrated Renal Sciences Private Limited
Integrated Renal Sciences Private Limited is audited by L B AND ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| L B AND ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Integrated Renal Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Integrated Renal Sciences Private Limited
Integrated Renal Sciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Integrated Renal Sciences Private Limited
Employment history and EPFO contributions of people linked to Integrated Renal Sciences.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Integrated Renal Sciences Private Limited
Integrated Renal Sciences has 2 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Renmed Healthcare Private Limited | U74999DL2018PTC340189 | Locked |
| Integrated Kidney Solutions Private Limited | U85100DL2020PTC360723 | Locked |
Showing major subsidiaries. Total: 2.
Recent Activity on Integrated Renal Sciences Private Limited
Integrated Renal Sciences Private Limited has 8 board changes on record since 2018: 4 appointments and 4 cessations. The latest: Mayank Sharma ceased to be Additional Director on 27 Nov 2021.
Credit Ratings, Litigation & Regulatory Alerts for Integrated Renal Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Integrated Renal Sciences Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Integrated Renal Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Integrated Renal Sciences Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Integrated Renal Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Integrated Renal Sciences Private Limited
Integrated Renal Sciences is an active private limited company based in New Delhi, Delhi, India. The company works in renal care and dialysis clinics, within the healthcare industry. It was incorporated on 16 March 2018 (8+ years old) and is registered under CIN U74999DL2018PTC331039.
Integrated Renal Sciences reported revenue of ₹23.66 Cr for FY 2025 (up 54% YoY).
Integrated Renal Sciences has 4 current directors:
- Vikas Verma - Director
- Ashish Tyagi - Director
- Rakesh Kumar Thakur - Director
- Mayank Sharma - Director
Integrated Renal Sciences reported a net loss of ₹3.14 Cr (net margin -13.3%) and EBITDA of -₹2.37 Cr (EBITDA margin -10%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Integrated Renal Sciences is 374% over three years. In the latest year (FY 2025) revenue rose 54%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Integrated Renal Sciences is U74999DL2018PTC331039. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Integrated Renal Sciences was incorporated on 16 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Integrated Renal Sciences by revenue are Rahi Care Private Limited, Fresenius Medical Care Dialysis Services India Private Limited, Asian Institute of Nephrology and Urology (Siliguri) Private Limited, Dr Raghoji Kidney Hospital and Research Centre Private Limited, DM Hospitals Private Limited and 5 more, all in the Healthcare industry (Renal Care).
Mayank Sharma ceased to be Additional Director on 27 Nov 2021. Vikas Verma ceased to be Additional Director on 27 Nov 2021. Mayank Sharma was appointed as Director on 25 May 2021. Integrated Renal Sciences has 8 board changes on record in total.
The registered office of Integrated Renal Sciences is at No.25A & 25B Hauz Rani Malviya Nagar, New Delhi, Delhi, India – 110017.
Integrated Renal Sciences has an authorised share capital of ₹1.31 Cr and a paid-up capital of ₹1.24 Cr.